Schlenker provided guidance: "For the third quarter 2025, as compared to 1 year prior, we expect revenues before reimbursements to be up in the middle single digits and EBITDA to be 26.75% to 27.75% ...

Scientific consulting firm Exponent (NASDAQ:EXPO) reported revenue ahead of Wall Street’s expectations in Q4 CY2025, with sales up 19.1% year on year to $147.4 million. Its GAAP profit of $0.49 per ...

Exponent's Q4 2024 earnings and revenue exceeded forecasts. Stock price increased by 3.54% in after-hours trading. Full-year 2024 revenues grew by 4% to $558.5 million. The company reported a 28.4% ...

Exponent (EXPO) came out with quarterly earnings of $0.46 per share, beating the Zacks Consensus Estimate of $0.40 per share. This compares to earnings of $0.41 per share a year ago. These figures are ...

Good day, and welcome to the Exponent, Inc. Fourth Quarter and Fiscal Year 2025 Earnings Conference Call. [Operator Instructions] Please note that this event is being recorded. I would now like to ...

Schlenker provided guidance for the fourth quarter, stating, "We expect revenues before reimbursements to grow in the low to mid-single digits, EBITDA to be 26% to 27% of revenues before ...